In May 2015 the private foundation (“Private Stichting”) Désiré Collen and the non-profit organisation “Life Sciences Research
Partners” founded Fund+. The Fund has the legal form of a Belgian Naamloze Vennootschap/Société Anonyme (NV/SA) and has its
registered offices in Groot Begijnhof of Leuven, a World Heritage Site.
Fund+ will invest in innovative life sciences companies primarily active in therapeutics, without excluding however companies
developing diagnostics and medical devices. The companies will be seeking for a series A or B financing and will have already a
Proof of Concept (POC). Fund+ aims at realizing an attractive financial return as well as a societal return. Fund+ wants to contribute
in a sustainable way to the improvement of the eco system for biotech companies. Therefore, its major geographical focus will be
As of today Fund+ has raised 200 Mio euro of financing commitments. The investors are high net worth individuals, family offices
and governmental agencies, which all share the same long term vision and societal values of the founders. The intended
investment size per company will be between 3 and 10 mio euro spread over different milestones. Currently, Fund+ counts 10
companies in its portfolio.